The Lancet Neurology in conversation with

187 Episodes

1. William Jagust on amyloid β and cognition

   Published: 8/16/2023
2. Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury

   Published: 7/19/2023
3. Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases

   Published: 6/21/2023
4. Andrew Cole on the complexities underlying epilepsy in people with glioblastoma

   Published: 5/18/2023
5. Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation

   Published: 4/13/2023
6. Kerstin Hellwig on family planning considerations in MS

   Published: 3/15/2023
7. Geraldine Dawson on advances in the prediction of autism during infancy

   Published: 2/16/2023
8. Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke

   Published: 1/19/2023
9. Beau Ances on amyloid biomarkers in Alzheimer’s

   Published: 12/12/2022
10. Axel Petzold on the diagnosis and classification of optic neuritis

    Published: 11/16/2022
11. Maeike Zijlmans on using biomarkers to tailor epilepsy surgery

    Published: 10/18/2022
12. Jerome Siegel on sleep habits

    Published: 9/14/2022
13. Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy

    Published: 8/10/2022
14. Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

    Published: 7/13/2022
15. Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

    Published: 6/15/2022
16. Mark Hallett on functional neurological disorder

    Published: 5/13/2022
17. Eva Feldman on advances in understanding ALS

    Published: 4/13/2022
18. Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

    Published: 4/6/2022
19. John Collinge on a treatment for CJD

    Published: 3/16/2022
20. Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2

    Published: 2/22/2022